Diabetes treatment is constantly advancing, with new therapeutic options emerging to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a group of drugs that mimic the actions of https://mariahfbhy799760.losblogos.com/37914780/emerging-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment